Pharmaceuticals

US reinsurers wary of Indian pharma firms

By Nisha Das | 09 Mar 2004

Product patents a major issue at Bio Asia

By Our Corporate Bureau | 01 Mar 2004

Pfizer recalls liquid Gelusil

By Our Corporate Bureau | 28 Feb 2004

One more CoS for Orchid Chemicals

19 Feb 2004

Pharmexcil to be headquartered in Hyderabad

By Our Corporate Bureau | 10 Feb 2004

Sun Pharma to increase holdings in Caraco to 60 per cent

By Our Corporate Bureau | 09 Feb 2004

Nicholas Piramal Q3 growth up 76.1 per cent

By Mumbai: | 07 Feb 2004

Nicholas Piramal merges Canere Actives and Fine Chemicals Pvt. Ltd.

By Mumbai: | 07 Feb 2004

Sun Pharma logs healthy growth

By Venkatachari Jagannathan | 03 Feb 2004

Ranbaxy enters the field of herbal medicine

By New Delhi: | 22 Jan 2004

Orchid posts good Q3 performance

16 Jan 2004

USFDA approval for Ranbaxy drug

By New Delhi: | 10 Jan 2004

Nicholas Piramal, SPPL debt programmes reaffirmed A1+

By Mumbai: | 06 Jan 2004

Vera Laboratories to come out with a preferential issue

By Our Markets Bureau | 02 Jan 2004

Orchid Aurangabad facility bags ISO 14001, OHSAS 18001

By Our Corporate Bureau | 31 Dec 2003

Divi''s, Matrix scrip prices cross leading pharma firms'' prices

By Nisha Das | 29 Dec 2003

Nicholas Piramal buys partner''s 50% stake in Sarabhai Piramal

By Mumbai: | 26 Dec 2003

Indian pharmaceutical majors oppose EMR granted to Novartis

By Nisha Das | 23 Dec 2003

European approval for Orchid Chemical's drug

By Our Corporate Bureau | 18 Dec 2003

USFDA approval for Orchid

By Our Corporate Bureau | 05 Dec 2003

WHO declares pre-qualification of Ranbaxy''s Triviro-LNS tablets

By Mumbai: | 04 Dec 2003

Bexel to conduct human trials

By Our Corporate Bureau | 03 Dec 2003

Nicholas Piramal enters into alliance with Biogen Idec, USA

By Mumbai: | 02 Dec 2003

Torrent to increase presence, set up export base in Germany

By Our Corporate Bureau | 22 Nov 2003

Novo Nordisk unveils 2 insulin

By Our Corporate Bureau | 10 Nov 2003